Instead, in a 2019 Egyptian study, DKK1 had an AUROC of 83% with 87.3% sensitivity and 82.9% specificity in HCC (HCV-related) patients at a cut-off point of 8.92 ng/ml [78]. Here, DKK1 is linked to hepatocellular carcinoma.